Resources

The stability and shelf life of an eye drop container are directly determined by the packaging s ability to maintain a sterile barrier and provide high-resistance to oxygen transmission and moisture loss. By utilizing high-precision barrier testing and container-closure integrity (CCI) validation, manufacturers can prevent active ingredient degradation and microbial ingress, ensuring products remain safe until the period when eye drops expire. Continue reading

The pharmaceutical industry strategically transitioning toward sustainable practices, through the integration of Post-Consumer Recycled (PCR) materials and lightweight packaging strategies.

However, in a highly regulated environment, "eco-friendly" cannot come at the expense of "regulatory compliance," these shifts require precise quantification of Oxygen and Water Vapor Transmission Rates (OTR/WVTR), as recycled polymers and thinner walls can significantly alter the barrier and mechanical properties of the packaging material and integrity of the container closure system. Continue reading

Designing a "greener" pharma pack requires a sophisticated balance between environmental responsibility and the uncompromising requirements of sterile medical packaging. In the pharmaceutical industry, sustainability is achieved not only through end-of-life recyclability but also through material efficiency (source reduction) and waste prevention enabled by rigorous shelf life testing. Continue reading

To minimize management risk in gene and cell therapy packaging, organizations must implement a data-driven cold chain packaging validation strategy. This involves verifying container-closure integrity (CCI) after exposure to extreme temperatures, testing material robustness to prevent brittle failure, and ensuring label traceability remains intact despite a steep temperature gradient. Continue reading